GHIC is a New York-based nonprofit venture investor and impact capital allocator focused on global public health, health security and pandemic preparedness. It backs life sciences and HealthTech companies developing diagnostics, medical devices, vaccines, therapeutics, biomanufacturing and related technologies, and can deploy venture, fund-investment and partnership capital across the United States, Germany and low- and middle-income countries.